These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 18539963)

  • 1. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensemble methods for classification of patients for personalized medicine with high-dimensional data.
    Moon H; Ahn H; Kodell RL; Baek S; Lin CJ; Chen JJ
    Artif Intell Med; 2007 Nov; 41(3):197-207. PubMed ID: 17719213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
    Dressman HK; Berchuck A; Chan G; Zhai J; Bild A; Sayer R; Cragun J; Clarke J; Whitaker RS; Li L; Gray J; Marks J; Ginsburg GS; Potti A; West M; Nevins JR; Lancaster JM
    J Clin Oncol; 2007 Feb; 25(5):517-25. PubMed ID: 17290060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers.
    Glinsky GV
    Stem Cell Rev; 2007 Jan; 3(1):79-93. PubMed ID: 17873385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.
    Yu J; Yu J; Rhodes DR; Tomlins SA; Cao X; Chen G; Mehra R; Wang X; Ghosh D; Shah RB; Varambally S; Pienta KJ; Chinnaiyan AM
    Cancer Res; 2007 Nov; 67(22):10657-63. PubMed ID: 18006806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior.
    Lu YJ; Williamson D; Wang R; Summersgill B; Rodriguez S; Rogers S; Pritchard-Jones K; Campbell C; Shipley J
    Genes Chromosomes Cancer; 2003 Nov; 38(3):207-14. PubMed ID: 14506694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hunting for robust gene signature from cancer profiling data: sources of variability, different interpretations, and recent methodological developments.
    Xu JZ; Wong CW
    Cancer Lett; 2010 Oct; 296(1):9-16. PubMed ID: 20579805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic approaches to outcome prediction in prostate cancer.
    Febbo PG
    Cancer; 2009 Jul; 115(13 Suppl):3046-57. PubMed ID: 19544546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
    Mobasheri A; Airley R; Hewitt SM; Marples D
    Int J Oncol; 2005 May; 26(5):1149-58. PubMed ID: 15809704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise.
    Sun Z; Yang P
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2063-8. PubMed ID: 17119029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction.
    Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R153-7. PubMed ID: 12928487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer gene profiling for response prediction.
    Ghadimi BM; Grade M
    Methods Mol Biol; 2010; 576():327-39. PubMed ID: 19882269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.
    Anguiano A; Potti A
    Expert Rev Mol Diagn; 2007 Nov; 7(6):837-44. PubMed ID: 18020912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving toward individualized cancer therapies.
    Tonon G; Anderson KC
    Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
    Miller LD; Liu ET
    Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of oncoproteomics in the personalized management of cancer.
    Jain KK
    Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.